vs

Side-by-side financial comparison of Allstate (ALL) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

Allstate is the larger business by last-quarter revenue ($922.0M vs $510.9M, roughly 1.8× Genius Sports Ltd). Allstate runs the higher net margin — 266.6% vs -12.3%, a 278.9% gap on every dollar of revenue. Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs -75.8%).

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection; Protection Services; Allstate Health and Benefits; and Run-off Property-Liability segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal ...

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

ALL vs GENI — Head-to-Head

Bigger by revenue
ALL
ALL
1.8× larger
ALL
$922.0M
$510.9M
GENI
Higher net margin
ALL
ALL
278.9% more per $
ALL
266.6%
-12.3%
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
-75.8%
ALL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALL
ALL
GENI
GENI
Revenue
$922.0M
$510.9M
Net Profit
$2.5B
$-63.0M
Gross Margin
25.2%
Operating Margin
-1400.3%
-11.5%
Net Margin
266.6%
-12.3%
Revenue YoY
7.2%
Net Profit YoY
EPS (diluted)
$9.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALL
ALL
GENI
GENI
Q1 26
$922.0M
Q4 25
$17.3B
$510.9M
Q3 25
$17.3B
$335.4M
Q2 25
$16.6B
$215.2M
Q1 25
$16.5B
$119.7M
Q4 24
$16.5B
$413.0M
Q3 24
$16.6B
$285.8M
Q2 24
$15.7B
$184.1M
Net Profit
ALL
ALL
GENI
GENI
Q1 26
$2.5B
Q4 25
$3.8B
$-63.0M
Q3 25
$3.7B
Q2 25
$2.1B
$-47.3M
Q1 25
$595.0M
$-25.5M
Q4 24
$1.9B
$-85.5M
Q3 24
$1.2B
$-47.1M
Q2 24
$331.0M
$-35.5M
Gross Margin
ALL
ALL
GENI
GENI
Q1 26
Q4 25
25.2%
Q3 25
24.2%
Q2 25
19.1%
Q1 25
10.7%
Q4 24
16.7%
Q3 24
20.5%
Q2 24
18.6%
Operating Margin
ALL
ALL
GENI
GENI
Q1 26
-1400.3%
Q4 25
-11.5%
Q3 25
-15.3%
Q2 25
-21.0%
Q1 25
-20.3%
Q4 24
-18.0%
Q3 24
-13.9%
Q2 24
-16.8%
Net Margin
ALL
ALL
GENI
GENI
Q1 26
266.6%
Q4 25
22.1%
-12.3%
Q3 25
21.7%
Q2 25
12.7%
-22.0%
Q1 25
3.6%
-21.3%
Q4 24
11.7%
-20.7%
Q3 24
7.2%
-16.5%
Q2 24
2.1%
-19.3%
EPS (diluted)
ALL
ALL
GENI
GENI
Q1 26
$9.25
Q4 25
$14.24
Q3 25
$13.95
Q2 25
$7.76
Q1 25
$2.11
Q4 24
$7.07
Q3 24
$4.33
Q2 24
$1.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALL
ALL
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$280.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$31.6B
$724.5M
Total Assets
$124.0B
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALL
ALL
GENI
GENI
Q1 26
Q4 25
$4.9B
$280.6M
Q3 25
$8.7B
$110.2M
Q2 25
$9.6B
$110.2M
Q1 25
$6.5B
$110.2M
Q4 24
$4.5B
$100.3M
Q3 24
$7.0B
$100.3M
Q2 24
$5.3B
$100.3M
Total Debt
ALL
ALL
GENI
GENI
Q1 26
Q4 25
$7.5B
Q3 25
$8.1B
Q2 25
$8.1B
Q1 25
$8.1B
Q4 24
$8.1B
Q3 24
$8.1B
Q2 24
$8.1B
Stockholders' Equity
ALL
ALL
GENI
GENI
Q1 26
$31.6B
Q4 25
$30.6B
$724.5M
Q3 25
$27.5B
$572.4M
Q2 25
$24.0B
$572.4M
Q1 25
$22.1B
$572.4M
Q4 24
$21.4B
$573.0M
Q3 24
$20.9B
$573.0M
Q2 24
$18.6B
$573.0M
Total Assets
ALL
ALL
GENI
GENI
Q1 26
$124.0B
Q4 25
$119.8B
$1.1B
Q3 25
$120.4B
$792.3M
Q2 25
$115.9B
$792.3M
Q1 25
$115.2B
$792.3M
Q4 24
$111.6B
$775.7M
Q3 24
$113.7B
$775.7M
Q2 24
$108.4B
$775.7M
Debt / Equity
ALL
ALL
GENI
GENI
Q1 26
Q4 25
0.24×
Q3 25
0.29×
Q2 25
0.34×
Q1 25
0.37×
Q4 24
0.38×
Q3 24
0.39×
Q2 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALL
ALL
GENI
GENI
Operating Cash FlowLast quarter
$81.9M
Free Cash FlowOCF − Capex
$69.6M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALL
ALL
GENI
GENI
Q1 26
Q4 25
$3.0B
$81.9M
Q3 25
$3.3B
$-4.8M
Q2 25
$1.9B
$-1.2M
Q1 25
$2.0B
$-14.6M
Q4 24
$1.7B
$14.9M
Q3 24
$3.2B
$-9.2M
Q2 24
$2.4B
Free Cash Flow
ALL
ALL
GENI
GENI
Q1 26
Q4 25
$2.9B
$69.6M
Q3 25
$3.2B
$-14.2M
Q2 25
$1.9B
$-5.8M
Q1 25
$1.9B
$-16.0M
Q4 24
$1.7B
$11.3M
Q3 24
$3.1B
$-11.6M
Q2 24
$2.3B
FCF Margin
ALL
ALL
GENI
GENI
Q1 26
Q4 25
16.7%
13.6%
Q3 25
18.8%
-4.2%
Q2 25
11.3%
-2.7%
Q1 25
11.4%
-13.4%
Q4 24
10.0%
2.7%
Q3 24
18.9%
-4.1%
Q2 24
14.7%
Capex Intensity
ALL
ALL
GENI
GENI
Q1 26
Q4 25
0.5%
2.4%
Q3 25
0.3%
2.8%
Q2 25
0.0%
2.1%
Q1 25
0.6%
1.2%
Q4 24
0.3%
0.9%
Q3 24
0.4%
0.9%
Q2 24
0.4%
Cash Conversion
ALL
ALL
GENI
GENI
Q1 26
Q4 25
0.78×
Q3 25
0.88×
Q2 25
0.89×
Q1 25
3.30×
Q4 24
0.88×
Q3 24
2.69×
Q2 24
7.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons